@article {HORIGUCHI-YAMADA2631, author = {JUNKO HORIGUCHI-YAMADA and SATSUKI IWASE and TAKESHI KAWANO and HISASHI YAMADA}, title = {Pretreatment with Interferon-α Radiosensitizes Daudi Cells Modulating Gene Expression and Biomarkers}, volume = {25}, number = {4}, pages = {2631--2638}, year = {2005}, publisher = {International Institute of Anticancer Research}, abstract = {Background: Interferon (IFN) potentiates cytotoxicity by X-ray irradiation. To elucidate the mechanism of this potentiation, the biological markers related to DNA damage and cell survival were studied. Materials and Methods: IFN-α-sensitive Daudi and its resistant cells were used. Survival after treatment was assessed by clonogenic assays. DNA breaks were studied by pulse-field gel electrophoresis (PFGE). Production of reactive oxygen metabolites was measured using flow cytometry. Messenger RNA and protein were examined by RT-PCR and immunoblot, respectively. Results: IFN-α treatment for 24 h before irradiation potentiated the sensitivity of Daudi cells to X-rays. This combination induced 50 kb DNA fragmentation and activated caspase-3 in Daudi cells. Pretreatment with IFN-α inhibited the production of reactive oxygen species by irradiation. IFN-α pretreatment down-regulated most of the double-strand break (DSB) repair-related mRNAs, but did not affect the repair of DSBs studied by PFGE. The induction and phosphorylation of p21Cip1/WAF1 (p21) was prominently suppressed in cells pretreated with IFN-α. Conclusion: Pretreatment with IFN-α potentiates the cytotoxic effects of X-rays. Inhibition of X-ray-induced p21 may cause the augmented sensitivity by IFN-α pretreatment. Copyright{\textcopyright} 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved}, issn = {0250-7005}, URL = {https://ar.iiarjournals.org/content/25/4/2631}, eprint = {https://ar.iiarjournals.org/content/25/4/2631.full.pdf}, journal = {Anticancer Research} }